Multiple Antigens of Yersinia Pestis Delivered by Live Recombinant Attenuated Salmonella Vaccine Strains Elicit Protective Immunity Against Plague
Overview
Affiliations
Based on our improved novel Salmonella vaccine delivery platform, we optimized the recombinant attenuated Salmonella typhimurium vaccine (RASV) χ12094 to deliver multiple Yersinia pestis antigens. These included LcrV196 (amino acids, 131-326), Psn encoded on pYA5383 and F1 encoded in the chromosome, their synthesis did not cause adverse effects on bacterial growth. Oral immunization with χ12094(pYA5383) simultaneously stimulated high antibody titers to LcrV, Psn and F1 in mice and presented complete protection against both subcutaneous (s.c.) and intranasal (i.n.) challenges with high lethal doses of Y. pestis CO92. Moreover, no deaths or other disease symptoms were observed in SCID mice orally immunized with χ12094(pYA5383) over a 60-day period. Therefore, the trivalent S. typhimurium-based live vaccine shows promise for a next-generation plague vaccine.
Combatting Salmonella: a focus on antimicrobial resistance and the need for effective vaccination.
Nazir J, Manzoor T, Saleem A, Gani U, Bhat S, Khan S BMC Infect Dis. 2025; 25(1):84.
PMID: 39833704 PMC: 11744889. DOI: 10.1186/s12879-025-10478-5.
Hendrix E, Sha J, Kilgore P, Neil B, Verma A, Chopra A Vaccines (Basel). 2025; 12(12.
PMID: 39772023 PMC: 11680114. DOI: 10.3390/vaccines12121361.
Progress on the research and development of plague vaccines with a call to action.
Williamson E, Kilgore P, Hendrix E, Neil B, Sha J, Chopra A NPJ Vaccines. 2024; 9(1):162.
PMID: 39242587 PMC: 11379892. DOI: 10.1038/s41541-024-00958-1.
Ghasemi A, Wang S, Sahay B, Abbott J, Curtiss 3rd R Front Immunol. 2022; 13:1034683.
PMID: 36466847 PMC: 9716130. DOI: 10.3389/fimmu.2022.1034683.
Loh F, Nathan S, Chow S, Fang C Pathog Glob Health. 2021; 115(6):392-404.
PMID: 33525974 PMC: 8592622. DOI: 10.1080/20477724.2021.1881369.